Hjem › Type 1-diabetes › Virginia
Type 1-diabetes kliniske forsøg i Virginia
10 studier for Type 1-diabetes søger deltagere på steder i Virginia.
Byer i Virginia
Officiel studietekst (engelsk)
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
- University of Virginia, Charlottesville
RekruttererFase 3
Alder 1 til 35 · Alle køn · Opdateret 22. sep. 2026 · NCT07222137A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
- University of Virginia, Charlottesville
RekruttererFase 3
Alder 1 til 35 · Alle køn · Opdateret 22. sep. 2026 · NCT07222332A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- Uva Children's Battle Building- Site Number : 8400060, Charlottesville
RekruttererFase 3
Alder 1 til 25 · Alle køn · Opdateret 14. sep. 2026 · NCT07088068A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
- VCU Medical Center, Richmond, Richmond
RekruttererFase 3
Alder 18 til 65 · Alle køn · Opdateret 1. sep. 2026 · NCT04786262SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
- University of Virginia Health System - Pediatric Diabetes Clinic, Charlottesville
RekruttererFase 2
Alder 5 til 40 · Alle køn · Opdateret 24. aug. 2026 · NCT07187531INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
- University of Virginia, Charlottesville
RekruttererFase 2
Alder 6 til 17 · Alle køn · Opdateret 13. aug. 2026 · NCT07224321Insulin Delivery With Self-Adjusting Closed-Loop and Behavioral Glycemic Control Enhanced by Prediction
- University of Virginia Center for Diabetes Technology, Charlottesville
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 22. jun. 2026 · NCT07507708Impact of Obesity on Microvascular Insulin Action and Cardiorespiratory Fitness in Type 1 Diabetes
- University of Virginia, Charlottesville
RekruttererFrivillige med god helbredstilstand velkomne
Alder 21 til 50 · Alle køn · Opdateret 7. maj 2026 · NCT07573228Artificial Pancreas Technology to Reduce Glycemic Variability and Improve Cardiovascular Health in Type 1 Diabetes
- University of Virginia Health System, Charlottesville
Rekrutterer
Alder 18 til 40 · Alle køn · Opdateret 25. feb. 2026 · NCT05653518Evaluation of a Novel Insulin Sensitizer in People With Type 1 Diabetes
- University of Virginia, Charlottesville
RekruttererFase 2
Alder 18 til 45 · Alle køn · Opdateret 25. feb. 2026 · NCT07186660Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.